{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:37:07Z","timestamp":1793191027743,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017723","name":"Innovent Biologics Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.eclinm.2025.103393","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T17:43:08Z","timestamp":1753810988000},"page":"103393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Neoadjuvant sintilimab and chemotherapy followed by transoral surgery for HPV-positive resectable oropharyngeal cancer: a single-arm, two-centre, phase 2 trial"],"prefix":"10.1016","volume":"86","author":[{"given":"Shida","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7495-5895","authenticated-orcid":false,"given":"Ming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"29","key":"10.1016\/j.eclinm.2025.103393_bib1","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus\u2013positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eclinm.2025.103393_bib2","series-title":"Presented at: international papillomavirus conference (IPVC) 2024","article-title":"The broaden-China study: increasing burden of human papillomavirus-related head and neck cancers in China","author":"Zhang","year":"2024"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103393_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2025.103393_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.oraloncology.2017.05.009","article-title":"Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer","volume":"71","author":"Dong","year":"2017","journal-title":"Oral Oncol"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103393_bib5","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.10567","article-title":"Squamous cell carcinoma of the oropharynx","volume":"94","author":"Parsons","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.eclinm.2025.103393_bib6","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-24-02550","article-title":"Long-term follow-up of E3311, an ECOG-ACRIN cancer research group phase II trial of transoral surgery and risk-based adjuvant treatment in human papillomavirus\u2013initiated oropharynx cancer","author":"Burtness","year":"2025","journal-title":"J Clin Oncol"},{"issue":"10212","key":"10.1016\/j.eclinm.2025.103393_bib7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103393_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002568","article-title":"Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial","volume":"9","author":"Ferris","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103393_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2024.1530","article-title":"Neoadjuvant nivolumab plus chemotherapy followed by response-adaptive therapy for HPV+ oropharyngeal cancer","volume":"10","author":"Rosenberg","year":"2024","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103393_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.21.01961","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial","volume":"40","author":"Nichols","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103393_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer research group trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103393_bib12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/hed.24526","article-title":"Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: a feasible novel approach","volume":"38","author":"Sadeghi","year":"2016","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103393_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoto.2023.3781","article-title":"Quality of life after neoadjuvant chemotherapy and transoral robotic surgery for oropharynx cancer","volume":"150","author":"Silver","year":"2024","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.eclinm.2025.103393_bib14","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103393_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"issue":"16","key":"10.1016\/j.eclinm.2025.103393_bib16","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"10.1016\/j.eclinm.2025.103393_bib17","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1093\/bioinformatics\/btu549","article-title":"FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution","volume":"30","author":"Newman","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103393_bib18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1186\/1471-2164-15-732","article-title":"Inferring copy number and genotype in tumour exome data","volume":"15","author":"Amarasinghe","year":"2014","journal-title":"BMC Genom"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103393_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103393_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"issue":"17","key":"10.1016\/j.eclinm.2025.103393_bib21","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103393_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"issue":"21","key":"10.1016\/j.eclinm.2025.103393_bib23","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1158\/1078-0432.CCR-19-2384","article-title":"HPV sequencing facilitates ultrasensitive detection of HPV circulating tumor DNA","volume":"27","author":"Leung","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103393_bib24","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1200\/JCO.1999.17.3.1008","article-title":"Quality of life in head and neck cancer patients: validation of the European organization for research and treatment of cancer quality of life questionnaire-H&N35","volume":"17","author":"Bjordal","year":"1999","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.eclinm.2025.103393_bib25","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0959-8049(00)00186-6","article-title":"A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H& N35) in head and neck patients","volume":"36","author":"Bjordal","year":"2000","journal-title":"Eur J Cancer"},{"issue":"13","key":"10.1016\/j.eclinm.2025.103393_bib26","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1158\/1078-0432.CCR-19-3977","article-title":"Impact of neoadjuvant durvalumab with or without tremelimumab on CD8(+) tumor lymphocyte density, safety, and efficacy in patients with oropharynx cancer: CIAO trial results","volume":"26","author":"Ferrarotto","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.1016\/j.eclinm.2025.103393_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246309","article-title":"Genomic and molecular profiling of human papillomavirus associated head and neck squamous cell carcinoma treated with immune checkpoint blockade compared to survival outcomes","volume":"13","author":"Shaikh","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103393_bib28","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1002\/ijc.32412","article-title":"Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx","volume":"145","author":"Dogan","year":"2019","journal-title":"Int J Cancer"},{"issue":"10166","key":"10.1016\/j.eclinm.2025.103393_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"issue":"10166","key":"10.1016\/j.eclinm.2025.103393_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103393_bib31","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2024.08.014","article-title":"Interim futility results of NRG-HN005, A randomized, phase II\/III non-inferiority trial for non-smoking p16+ oropharyngeal cancer patients","volume":"120","author":"Yom","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103393_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx\u2014 ECOG-ACRIN cancer research group","volume":"35","author":"Marur","year":"2017","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103393_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/annonc\/mdy522","article-title":"OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer","volume":"30","author":"Seiwert","year":"2019","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103393_bib34","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/hed.26147","article-title":"Neoadjuvant chemotherapy followed by surgery for HPV-associated locoregionally advanced oropharynx cancer","volume":"42","author":"Sadeghi","year":"2020","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103393_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamaoto.2021.2191","article-title":"Neoadjuvant PD-1\/PD-L1 inhibitors for resectable head and neck cancer: a systematic review and meta-analysis","volume":"147","author":"Masarwy","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103393_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/hed.26022","article-title":"Pathologic response to neoadjuvant chemotherapy in HPV-associated oropharynx cancer","volume":"42","author":"Sadeghi","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.eclinm.2025.103393_bib37","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2415434","article-title":"Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer","author":"Uppaluri","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103393_bib38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s12094-023-03342-y","article-title":"Neoadjuvant chemoimmunotherapy shows major pathological response and low recurrence in head and neck squamous cell carcinoma","volume":"26","author":"Yan","year":"2023","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103393_bib39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ijrobp.2014.12.045","article-title":"Long-term quality of life after swallowing and salivary-sparing chemo\u2013intensity modulated radiation therapy in survivors of human papillomavirus\u2013related oropharyngeal cancer","volume":"91","author":"Vainshtein","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103393_bib40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eclinm.2025.103393_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/ohn.1261","article-title":"Patient-reported swallowing outcomes in HPV+ oropharyngeal cancer by postoperative chemoradiation dose in MINT and E3311","author":"Tharakan","year":"2025","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103393_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-53830-0","article-title":"A proteogenomic analysis of cervical cancer reveals therapeutic and biological insights","volume":"15","author":"Yu","year":"2024","journal-title":"Nat Commun"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025003256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025003256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T08:13:08Z","timestamp":1755850388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025003256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"alternative-id":["S2589537025003256"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103393","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant sintilimab and chemotherapy followed by transoral surgery for HPV-positive resectable oropharyngeal cancer: a single-arm, two-centre, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103393"}}